Approved and investigational biologics typically are delivered via intravenous administration that can require expensive, inconvenient and routine hospital or clinic visits. Enable Injections LLC expects that it has a solution with its subcutaneous drug delivery wearable – and the multiple pharma partners it has lined up, including Paris-based Sanofi SA, apparently agree.